Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Myasthenic syndrome
ADR ID BADD_A02914
ADR Hierarchy
10      Immune system disorders
10.04      Autoimmune disorders
10.04.05      Muscular autoimmune disorders
10.04.05.005      Myasthenic syndrome
15      Musculoskeletal and connective tissue disorders
15.05      Muscle disorders
15.05.08      Myasthenia gravis and related conditions
15.05.08.003      Myasthenic syndrome
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.32      Neoplasm related morbidities
16.32.01      Paraneoplastic syndromes NEC
16.32.01.002      Myasthenic syndrome
17      Nervous system disorders
17.05      Neuromuscular disorders
17.05.04      Neuromuscular junction dysfunction
17.05.04.004      Myasthenic syndrome
Description An autoimmune disease characterized by weakness and fatigability of proximal muscles, particularly of the pelvic girdle, lower extremities, trunk, and shoulder girdle. There is relative sparing of extraocular and bulbar muscles. CARCINOMA, SMALL CELL of the lung is a frequently associated condition, although other malignancies and autoimmune diseases may be associated. Muscular weakness results from impaired impulse transmission at the NEUROMUSCULAR JUNCTION. Presynaptic calcium channel dysfunction leads to a reduced amount of acetylcholine being released in response to stimulation of the nerve. (From Adams et al., Principles of Neurology, 6th ed, pp 1471) [MeSH]
MedDRA Code 10028424
MeSH ID D015624
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Eaton-Lambert syndrome | Myasthenia gravis-like paralysis | Myasthenia gravis-like reaction | Myasthenia gravis-like syndrome | Myasthenic syndrome | Myasthenic syndromes in diseases classified elsewhere | Reaction myasthenia gravis-like | Drug-induced myasthenic syndrome | Lambert-Eaton myasthenic syndrome | Paraneoplastic myasthenic syndrome | Lambert-Eaton Myasthenic Syndrome | Lambert Eaton Myasthenic Syndrome | Eaton-Lambert Myasthenic Syndrome | Eaton Lambert Myasthenic Syndrome | Myasthenic Syndrome, Eaton-Lambert | Syndrome, Eaton-Lambert Myasthenic | Myasthenic Syndrome, Lambert-Eaton | Myasthenic Syndrome, Lambert Eaton | Syndrome, Lambert-Eaton Myasthenic | Myopathic-Myasthenic Syndrome of Lambert-Eaton | Lambert-Eaton Myopathic-Myasthenic Syndrome | Lambert-Eaton Myopathic-Myasthenic Syndromes | Lambert-Eaton Syndrome | Lambert Eaton Syndrome | Syndrome, Lambert-Eaton | Myasthenic-Myopathic Syndrome of Lambert-Eaton | Lambert-Eaton Myasthenic-Myopathic Syndrome | Lambert-Eaton Myasthenic-Myopathic Syndromes | Myasthenic Myopathic Syndrome of Lambert Eaton | Myopathic-Myasthenic Syndrome of Eaton-Lambert | Eaton-Lambert Myopathic-Myasthenic Syndrome | Eaton-Lambert Myopathic-Myasthenic Syndromes | Myopathic Myasthenic Syndrome of Eaton Lambert | Eaton-Lambert Syndrome | Eaton Lambert Syndrome | Syndrome, Eaton-Lambert | Myasthenic-Myopathic Syndrome of Eaton-Lambert | Eaton-Lambert Myasthenic-Myopathic Syndrome | Myasthenic Myopathic Syndrome of Eaton Lambert
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00511Clozapine--
BADD_D00605Demeclocycline--
BADD_D00606Demeclocycline hydrochloride--
BADD_D01003Ganciclovir--
BADD_D01016Gentamicin--
BADD_D01418Methotrexate0.000114%
BADD_D01507Mycophenolate mofetil--
BADD_D01765Phenytoin0.000191%
BADD_D01959Rocuronium0.000171%
BADD_D02060Sotalol0.000703%
BADD_D02160Terbinafine0.000298%
BADD_D02223Tiopronin--
BADD_D02287Trimethadione--
BADD_D02326Valganciclovir--
BADD_D02396Zonisamide--
The 1th Page    1    Total 1 Pages